Innovations Item Code: IN-2024-2100317
Sector: Health/Telemedicine
Description:
The innovation is a Micro-Jewelry Sensor (MJS) designed specifically to empower Chronic Obstructive Pulmonary Disease (COPD) patients in Nigeria. It merges wearable technology with real-time air quality monitoring to address the challenges of COPD management in a country significantly impacted by air pollution.
Here are the key features of the MJS:
- Real-time air quality monitoring: Equipped with a Sensirion SPS30 sensor, the MJS provides COPD patients with precise PM2.5 data to minimize exposure to pollution triggers.
- Personalized exposure assessment: The MJS factors in air quality data, user location, activity level, and health conditions to create personalized recommendations for COPD management.
- User-friendly design: The MJS is designed to be comfortable, discreet, and easy to use, promoting long-term data collection and continuous monitoring.
Overall, the MJS aims to improve respiratory health outcomes for COPD patients in Nigeria by providing real-time data, personalized insights, and the ability to make informed decisions about daily activities to reduce exposure to air pollution.
Stage of Innovation: Idea (You have thought it through and documented it)
Problem:
The MJS is trying to solve the challenge of managing COPD in Nigeria, a country with significant air pollution issues. Here's a breakdown of the problem:
- COPD prevalence: COPD is a common lung disease in Nigeria.
- Air pollution impact: Air pollution, particularly PM2.5, worsens COPD symptoms and triggers flare-ups.
- Limited air quality data: Lack of widespread, real-time air quality monitoring makes it difficult for COPD patients to avoid pollution triggers.
- Challenges in managing COPD: Traditional COPD management might not fully address the impact of air pollution on patients.
The MJS aims to address these issues by:
- Providing real-time air quality data: This empowers patients to minimize exposure to air pollution.
- Enabling personalized COPD management: By considering air quality and individual factors, the MJS allows for more targeted interventions.
Unique Selling Point: Current Practices: Medication: Patients rely on medications like inhalers and bronchodilators to manage COPD symptoms. Doctor consultations: Regular doctor visits allow for monitoring and potential medication adjustments. Limited air quality awareness: People might be generally aware of air pollution but may not have access to real-time data on PM2.5 levels. How the MJS is Different: . Focus on air quality: The MJS provides real-time PM2.5 monitoring, empowering patients to make informed decisions about daily activities to avoid high-pollution periods. . Personalized approach: The MJS goes beyond medication by considering individual factors and air quality data to suggest personalized actions for better COPD management. . Continuous monitoring: Unlike relying solely on doctor visits, the MJS offers continuous air quality data and potential insights into COPD triggers. . Portable and unobtrusive: The wearable design allows for constant monitoring and data collection without disrupting daily activities. Overall, the MJS complements existing COPD management strategies by providing a layer of real-time data and personalized recommendations specifically focused on air quality, a significant factor in Nigeria.